[
  {
    "title": "Vertex Receives CHMP Positive Opinion for Expanded Label for KAFTRIO\u00ae in Combination With Ivacaftor for People With Cystic Fibrosis to Include Rare Mutations",
    "published": 1740727383,
    "day_prices": {
      "2025-02-28T14:30:00+00:00": 479.8999938964844,
      "2025-02-28T15:30:00+00:00": 475.125,
      "2025-02-28T16:30:00+00:00": 475.8450012207031,
      "2025-02-28T17:30:00+00:00": 478.5,
      "2025-02-28T18:30:00+00:00": 476.7699890136719,
      "2025-02-28T19:30:00+00:00": 476.82000732421875,
      "2025-02-28T20:30:00+00:00": 479.3500061035156
    },
    "sentiment": 0.9442230463027954
  },
  {
    "title": "Hartford Healthcare Fund Q4 2024 Commentary",
    "published": 1740433380,
    "day_prices": {
      "2025-02-24T14:30:00+00:00": 482.8399963378906,
      "2025-02-24T15:30:00+00:00": 484.5,
      "2025-02-24T16:30:00+00:00": 479.69000244140625,
      "2025-02-24T17:30:00+00:00": 482.2900085449219,
      "2025-02-24T18:30:00+00:00": 481.7699890136719,
      "2025-02-24T19:30:00+00:00": 481.3100891113281,
      "2025-02-24T20:30:00+00:00": 482.3299865722656
    },
    "sentiment": 0.9467632174491882
  },
  {
    "title": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "published": 1740069480,
    "day_prices": {
      "2025-02-20T14:30:00+00:00": 474.010009765625,
      "2025-02-20T15:30:00+00:00": 476.17999267578125,
      "2025-02-20T16:30:00+00:00": 477.1650085449219,
      "2025-02-20T17:30:00+00:00": 473.8699951171875,
      "2025-02-20T18:30:00+00:00": 480.15478515625,
      "2025-02-20T19:30:00+00:00": 479.2749938964844,
      "2025-02-20T20:30:00+00:00": 479.30999755859375
    },
    "sentiment": 0.9419764280319214
  },
  {
    "title": "Parnassus Growth Equity Fund Q4 And 2024 Annual Investment Commentary",
    "published": 1739778900,
    "day_prices": {},
    "sentiment": 0.9280773401260376
  },
  {
    "title": "Janus Henderson Global Life Sciences Diversified ADR Managed Account Q4 2024 Commentary",
    "published": 1739480280,
    "day_prices": {
      "2025-02-13T14:30:00+00:00": 454.8299865722656,
      "2025-02-13T15:30:00+00:00": 452.8800048828125,
      "2025-02-13T16:30:00+00:00": 457.57000732421875,
      "2025-02-13T17:30:00+00:00": 459.30999755859375,
      "2025-02-13T18:30:00+00:00": 460.114990234375,
      "2025-02-13T19:30:00+00:00": 463.7774963378906,
      "2025-02-13T20:30:00+00:00": 462.32000732421875
    },
    "sentiment": 0.9473699927330017
  },
  {
    "title": "Janus Henderson Global Life Sciences Fund Q4 2024 Commentary",
    "published": 1739392800,
    "day_prices": {
      "2025-02-12T14:30:00+00:00": 451.82000732421875,
      "2025-02-12T15:30:00+00:00": 453.4800109863281,
      "2025-02-12T16:30:00+00:00": 449.70001220703125,
      "2025-02-12T17:30:00+00:00": 450.760009765625,
      "2025-02-12T18:30:00+00:00": 446.8800048828125,
      "2025-02-12T19:30:00+00:00": 446.5639953613281,
      "2025-02-12T20:30:00+00:00": 451.0050048828125
    },
    "sentiment": 0.9430727958679199
  },
  {
    "title": "Vertex Posts 'Another Impressive Quarterly Revenue Beat.' But The Future Remains Uncertain.",
    "published": 1739265649,
    "day_prices": {
      "2025-02-11T14:30:00+00:00": 460.0,
      "2025-02-11T15:30:00+00:00": 460.75,
      "2025-02-11T16:30:00+00:00": 461.0899963378906,
      "2025-02-11T17:30:00+00:00": 459.29998779296875,
      "2025-02-11T18:30:00+00:00": 459.6499938964844,
      "2025-02-11T19:30:00+00:00": 458.67999267578125,
      "2025-02-11T20:30:00+00:00": 457.1499938964844
    },
    "sentiment": 0.39063137769699097
  },
  {
    "title": "Vertex Pharmaceuticals Incorporated 2024 Q4 - Results - Earnings Call Presentation",
    "published": 1739212954,
    "day_prices": {
      "2025-02-10T14:30:00+00:00": 471.94000244140625,
      "2025-02-10T15:30:00+00:00": 467.5849914550781,
      "2025-02-10T16:30:00+00:00": 470.3800048828125,
      "2025-02-10T17:30:00+00:00": 470.06500244140625,
      "2025-02-10T18:30:00+00:00": 469.3800048828125,
      "2025-02-10T19:30:00+00:00": 468.8299865722656,
      "2025-02-10T20:30:00+00:00": 467.8800048828125
    },
    "sentiment": 0.932439386844635
  },
  {
    "title": "Tweedy, Browne Fund Q2 2024 Commentary",
    "published": 1739186400,
    "day_prices": {
      "2025-02-10T14:30:00+00:00": 471.94000244140625,
      "2025-02-10T15:30:00+00:00": 467.5849914550781,
      "2025-02-10T16:30:00+00:00": 470.3800048828125,
      "2025-02-10T17:30:00+00:00": 470.06500244140625,
      "2025-02-10T18:30:00+00:00": 469.3800048828125,
      "2025-02-10T19:30:00+00:00": 468.8299865722656,
      "2025-02-10T20:30:00+00:00": 467.8800048828125
    },
    "sentiment": 0.9420115351676941
  },
  {
    "title": "2 Biotech Stocks to Buy Hand Over Fist in February",
    "published": 1739117700,
    "day_prices": {},
    "sentiment": 0.5234915018081665
  },
  {
    "title": "What To Expect in the Markets This Week",
    "published": 1739095200,
    "day_prices": {},
    "sentiment": 0.9187409281730652
  },
  {
    "title": "Consumer Companies In Focus Next Week As McDonald's, Coca-Cola, Unilever Report Earnings",
    "published": 1739012400,
    "day_prices": {},
    "sentiment": 0.9017478823661804
  },
  {
    "title": "Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
    "published": 1738946220,
    "day_prices": {
      "2025-02-07T14:30:00+00:00": 478.9800109863281,
      "2025-02-07T15:30:00+00:00": 475.3500061035156,
      "2025-02-07T16:30:00+00:00": 472.7900085449219,
      "2025-02-07T17:30:00+00:00": 472.8500061035156,
      "2025-02-07T18:30:00+00:00": 473.1400146484375,
      "2025-02-07T19:30:00+00:00": 473.55499267578125,
      "2025-02-07T20:30:00+00:00": 471.2049865722656
    },
    "sentiment": 0.9509263038635254
  },
  {
    "title": "The Zacks Analyst Blog Highlights Amgen, CRISPR, Moderna, Sarepta and Vertex",
    "published": 1738837380,
    "day_prices": {
      "2025-02-06T14:30:00+00:00": 487.7900085449219,
      "2025-02-06T15:30:00+00:00": 486.0199890136719,
      "2025-02-06T16:30:00+00:00": 484.0450134277344,
      "2025-02-06T17:30:00+00:00": 482.010009765625,
      "2025-02-06T18:30:00+00:00": 483.1000061035156,
      "2025-02-06T19:30:00+00:00": 482.31500244140625,
      "2025-02-06T20:30:00+00:00": 479.17498779296875
    },
    "sentiment": 0.9321796298027039
  },
  {
    "title": "Is VRTX a Portfolio Must Have After Two FDA Nods Ahead of Q4 Earnings?",
    "published": 1738767240,
    "day_prices": {
      "2025-02-05T14:30:00+00:00": 485.0,
      "2025-02-05T15:30:00+00:00": 488.7099914550781,
      "2025-02-05T16:30:00+00:00": 487.92999267578125,
      "2025-02-05T17:30:00+00:00": 486.3800048828125,
      "2025-02-05T18:30:00+00:00": 489.32501220703125,
      "2025-02-05T19:30:00+00:00": 491.0249938964844,
      "2025-02-05T20:30:00+00:00": 487.6400146484375
    },
    "sentiment": 0.8949188590049744
  },
  {
    "title": "ClearBridge Growth Portfolios Q4 2024 Commentary",
    "published": 1738743300,
    "day_prices": {
      "2025-02-05T14:30:00+00:00": 485.0,
      "2025-02-05T15:30:00+00:00": 488.7099914550781,
      "2025-02-05T16:30:00+00:00": 487.92999267578125,
      "2025-02-05T17:30:00+00:00": 486.3800048828125,
      "2025-02-05T18:30:00+00:00": 489.32501220703125,
      "2025-02-05T19:30:00+00:00": 491.0249938964844,
      "2025-02-05T20:30:00+00:00": 487.6400146484375
    },
    "sentiment": 0.9520075917243958
  },
  {
    "title": "Vertex Pharma Just Scored a Major FDA Approval. Is the Stock a No-Brainer Buy Now?",
    "published": 1738671000,
    "day_prices": {
      "2025-02-04T14:30:00+00:00": 468.0400085449219,
      "2025-02-04T15:30:00+00:00": 471.8500061035156,
      "2025-02-04T16:30:00+00:00": 476.2349853515625,
      "2025-02-04T17:30:00+00:00": 478.2149963378906,
      "2025-02-04T18:30:00+00:00": 477.8900146484375,
      "2025-02-04T19:30:00+00:00": 479.65350341796875,
      "2025-02-04T20:30:00+00:00": 479.3299865722656
    },
    "sentiment": 0.8527134656906128
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note",
    "published": 1738623022,
    "day_prices": {
      "2025-02-03T14:30:00+00:00": 463.3599853515625,
      "2025-02-03T15:30:00+00:00": 462.25360107421875,
      "2025-02-03T16:30:00+00:00": 464.7349853515625,
      "2025-02-03T17:30:00+00:00": 468.0899963378906,
      "2025-02-03T18:30:00+00:00": 468.2349853515625,
      "2025-02-03T19:30:00+00:00": 470.5450134277344,
      "2025-02-03T20:30:00+00:00": 470.2900085449219
    },
    "sentiment": 0.8930268287658691
  },
  {
    "title": "3 Magnificent Stocks to Buy and Hold Forever",
    "published": 1738593000,
    "day_prices": {
      "2025-02-03T14:30:00+00:00": 463.3599853515625,
      "2025-02-03T15:30:00+00:00": 462.25360107421875,
      "2025-02-03T16:30:00+00:00": 464.7349853515625,
      "2025-02-03T17:30:00+00:00": 468.0899963378906,
      "2025-02-03T18:30:00+00:00": 468.2349853515625,
      "2025-02-03T19:30:00+00:00": 470.5450134277344,
      "2025-02-03T20:30:00+00:00": 470.2900085449219
    },
    "sentiment": 0.9410690665245056
  },
  {
    "title": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
    "published": 1738591212,
    "day_prices": {
      "2025-02-03T14:30:00+00:00": 463.3599853515625,
      "2025-02-03T15:30:00+00:00": 462.25360107421875,
      "2025-02-03T16:30:00+00:00": 464.7349853515625,
      "2025-02-03T17:30:00+00:00": 468.0899963378906,
      "2025-02-03T18:30:00+00:00": 468.2349853515625,
      "2025-02-03T19:30:00+00:00": 470.5450134277344,
      "2025-02-03T20:30:00+00:00": 470.2900085449219
    },
    "sentiment": 0.7639610767364502
  },
  {
    "title": "Vertex Pharmaceuticals Just Won a Huge FDA Approval. Is the Biotech Stock a No-Brainer Buy?",
    "published": 1738501560,
    "day_prices": {},
    "sentiment": 0.8578693866729736
  },
  {
    "title": "Vertex: Maintaining Buy Despite Tempered Expectations For Journavx In Pain",
    "published": 1738448271,
    "day_prices": {},
    "sentiment": 0.9357240796089172
  },
  {
    "title": "Vertex: YOY Decline In Q4 Earnings Expected, But Revenue Continues To Shine",
    "published": 1738396800,
    "day_prices": {},
    "sentiment": 0.9454638361930847
  },
  {
    "title": "abrdn Life Sciences Investors Q4 2024 Commentary",
    "published": 1743306600,
    "day_prices": {},
    "sentiment": 0.9462534785270691
  },
  {
    "title": "abrdn Healthcare Investors Q4 2024 Commentary",
    "published": 1743303000,
    "day_prices": {},
    "sentiment": 0.9452806711196899
  },
  {
    "title": "Is Vertex Pharmaceuticals (VRTX) The Most Expensive Stock Insiders Are Dumping In March?",
    "published": 1743203219,
    "day_prices": {
      "2025-03-28T13:30:00+00:00": 504.7900085449219,
      "2025-03-28T14:30:00+00:00": 498.8699951171875,
      "2025-03-28T15:30:00+00:00": 499.04998779296875,
      "2025-03-28T16:30:00+00:00": 498.94000244140625,
      "2025-03-28T17:30:00+00:00": 496.94000244140625,
      "2025-03-28T18:30:00+00:00": 495.1600036621094,
      "2025-03-28T19:30:00+00:00": 494.010009765625
    },
    "sentiment": 0.6490328907966614
  },
  {
    "title": "Vertex Announces Program Updates for Type 1 Diabetes Portfolio",
    "published": 1743192300,
    "day_prices": {
      "2025-03-28T13:30:00+00:00": 504.7900085449219,
      "2025-03-28T14:30:00+00:00": 498.8699951171875,
      "2025-03-28T15:30:00+00:00": 499.04998779296875,
      "2025-03-28T16:30:00+00:00": 498.94000244140625,
      "2025-03-28T17:30:00+00:00": 496.94000244140625,
      "2025-03-28T18:30:00+00:00": 495.1600036621094,
      "2025-03-28T19:30:00+00:00": 494.010009765625
    },
    "sentiment": 0.8222286105155945
  },
  {
    "title": "Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
    "published": 1743179820,
    "day_prices": {
      "2025-03-28T13:30:00+00:00": 504.7900085449219,
      "2025-03-28T14:30:00+00:00": 498.8699951171875,
      "2025-03-28T15:30:00+00:00": 499.04998779296875,
      "2025-03-28T16:30:00+00:00": 498.94000244140625,
      "2025-03-28T17:30:00+00:00": 496.94000244140625,
      "2025-03-28T18:30:00+00:00": 495.1600036621094,
      "2025-03-28T19:30:00+00:00": 494.010009765625
    },
    "sentiment": 0.9509263038635254
  },
  {
    "title": "Rattled by the Stock Market Sell-Off? These 3 Stocks Outperformed the S&P 500 During the Great Recession",
    "published": 1743157800,
    "day_prices": {
      "2025-03-28T13:30:00+00:00": 504.7900085449219,
      "2025-03-28T14:30:00+00:00": 498.8699951171875,
      "2025-03-28T15:30:00+00:00": 499.04998779296875,
      "2025-03-28T16:30:00+00:00": 498.94000244140625,
      "2025-03-28T17:30:00+00:00": 496.94000244140625,
      "2025-03-28T18:30:00+00:00": 495.1600036621094,
      "2025-03-28T19:30:00+00:00": 494.010009765625
    },
    "sentiment": 0.5909196734428406
  },
  {
    "title": "ClearBridge All Cap Growth Portfolios Q4 2024 Commentary",
    "published": 1743116100,
    "day_prices": {
      "2025-03-27T13:30:00+00:00": 498.5899963378906,
      "2025-03-27T14:30:00+00:00": 503.8599853515625,
      "2025-03-27T15:30:00+00:00": 503.9800109863281,
      "2025-03-27T16:30:00+00:00": 504.2850036621094,
      "2025-03-27T17:30:00+00:00": 502.8699951171875,
      "2025-03-27T18:30:00+00:00": 503.2699890136719,
      "2025-03-27T19:30:00+00:00": 503.82000732421875
    },
    "sentiment": 0.8858500719070435
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors",
    "published": 1743112816,
    "day_prices": {
      "2025-03-27T13:30:00+00:00": 498.5899963378906,
      "2025-03-27T14:30:00+00:00": 503.8599853515625,
      "2025-03-27T15:30:00+00:00": 503.9800109863281,
      "2025-03-27T16:30:00+00:00": 504.2850036621094,
      "2025-03-27T17:30:00+00:00": 502.8699951171875,
      "2025-03-27T18:30:00+00:00": 503.2699890136719,
      "2025-03-27T19:30:00+00:00": 503.82000732421875
    },
    "sentiment": 0.838131308555603
  },
  {
    "title": "Franklin Biotechnology Discovery Fund Q4 2024 Commentary",
    "published": 1743060600,
    "day_prices": {
      "2025-03-27T13:30:00+00:00": 498.5899963378906,
      "2025-03-27T14:30:00+00:00": 503.8599853515625,
      "2025-03-27T15:30:00+00:00": 503.9800109863281,
      "2025-03-27T16:30:00+00:00": 504.2850036621094,
      "2025-03-27T17:30:00+00:00": 502.8699951171875,
      "2025-03-27T18:30:00+00:00": 503.2699890136719,
      "2025-03-27T19:30:00+00:00": 503.82000732421875
    },
    "sentiment": 0.9198147058486938
  },
  {
    "title": "The Risk/Reward Of Avidity Biosciences And Its 2 Promising Programs",
    "published": 1742984229,
    "day_prices": {
      "2025-03-26T13:30:00+00:00": 503.19000244140625,
      "2025-03-26T14:30:00+00:00": 504.25250244140625,
      "2025-03-26T15:30:00+00:00": 502.8599853515625,
      "2025-03-26T16:30:00+00:00": 500.9100036621094,
      "2025-03-26T17:30:00+00:00": 502.6400146484375,
      "2025-03-26T18:30:00+00:00": 501.3699951171875,
      "2025-03-26T19:30:00+00:00": 501.1000061035156
    },
    "sentiment": 0.7583533525466919
  },
  {
    "title": "Vertex Pharmaceuticals Inc. stock rises Monday, still underperforms market",
    "published": 1742834160,
    "day_prices": {
      "2025-03-24T13:30:00+00:00": 504.989990234375,
      "2025-03-24T14:30:00+00:00": 510.2799987792969,
      "2025-03-24T15:30:00+00:00": 510.04998779296875,
      "2025-03-24T16:30:00+00:00": 510.4750061035156,
      "2025-03-24T17:30:00+00:00": 510.67999267578125,
      "2025-03-24T18:30:00+00:00": 511.02410888671875,
      "2025-03-24T19:30:00+00:00": 513.3499755859375
    },
    "sentiment": 0.6305317282676697
  },
  {
    "title": "2 Beaten-Down Stocks to Buy on the Dip",
    "published": 1742673840,
    "day_prices": {},
    "sentiment": 0.5873208045959473
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know",
    "published": 1742593817,
    "day_prices": {
      "2025-03-21T13:30:00+00:00": 505.42999267578125,
      "2025-03-21T14:30:00+00:00": 504.80999755859375,
      "2025-03-21T15:30:00+00:00": 503.7300109863281,
      "2025-03-21T16:30:00+00:00": 506.05999755859375,
      "2025-03-21T17:30:00+00:00": 505.010009765625,
      "2025-03-21T18:30:00+00:00": 504.74249267578125,
      "2025-03-21T19:30:00+00:00": 505.05999755859375
    },
    "sentiment": 0.8845348358154297
  },
  {
    "title": "As The Biotech Sector Remains Strong, Vertex Stock Trades Near Buy Point",
    "published": 1742558455,
    "day_prices": {
      "2025-03-21T13:30:00+00:00": 505.42999267578125,
      "2025-03-21T14:30:00+00:00": 504.80999755859375,
      "2025-03-21T15:30:00+00:00": 503.7300109863281,
      "2025-03-21T16:30:00+00:00": 506.05999755859375,
      "2025-03-21T17:30:00+00:00": 505.010009765625,
      "2025-03-21T18:30:00+00:00": 504.74249267578125,
      "2025-03-21T19:30:00+00:00": 505.05999755859375
    },
    "sentiment": 0.8267236948013306
  },
  {
    "title": "Invesco Health Care Fund Q4 2024 Commentary",
    "published": 1742461500,
    "day_prices": {
      "2025-03-20T13:30:00+00:00": 510.0,
      "2025-03-20T14:30:00+00:00": 513.1199951171875,
      "2025-03-20T15:30:00+00:00": 508.1325988769531,
      "2025-03-20T16:30:00+00:00": 508.6549987792969,
      "2025-03-20T17:30:00+00:00": 506.30499267578125,
      "2025-03-20T18:30:00+00:00": 507.6400146484375,
      "2025-03-20T19:30:00+00:00": 509.4649963378906
    },
    "sentiment": 0.944513738155365
  },
  {
    "title": "Is Vertex Pharmaceuticals (VRTX) the Best Diabetes Stock to Buy According to Billionaires?",
    "published": 1742393815,
    "day_prices": {
      "2025-03-19T13:30:00+00:00": 512.010009765625,
      "2025-03-19T14:30:00+00:00": 507.45001220703125,
      "2025-03-19T15:30:00+00:00": 505.93499755859375,
      "2025-03-19T16:30:00+00:00": 508.6099853515625,
      "2025-03-19T17:30:00+00:00": 507.8900146484375,
      "2025-03-19T18:30:00+00:00": 509.4599914550781,
      "2025-03-19T19:30:00+00:00": 513.6799926757812
    },
    "sentiment": 0.8465118408203125
  },
  {
    "title": "CRISPR Therapeutics AG (CRSP): A Bull Case Theory",
    "published": 1742391707,
    "day_prices": {
      "2025-03-19T13:30:00+00:00": 512.010009765625,
      "2025-03-19T14:30:00+00:00": 507.45001220703125,
      "2025-03-19T15:30:00+00:00": 505.93499755859375,
      "2025-03-19T16:30:00+00:00": 508.6099853515625,
      "2025-03-19T17:30:00+00:00": 507.8900146484375,
      "2025-03-19T18:30:00+00:00": 509.4599914550781,
      "2025-03-19T19:30:00+00:00": 513.6799926757812
    },
    "sentiment": 0.925820529460907
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX): One of the Best Biotech Stocks to Buy According to Billionaires",
    "published": 1742289975,
    "day_prices": {
      "2025-03-18T13:30:00+00:00": 510.29998779296875,
      "2025-03-18T14:30:00+00:00": 513.6599731445312,
      "2025-03-18T15:30:00+00:00": 515.7650146484375,
      "2025-03-18T16:30:00+00:00": 514.364990234375,
      "2025-03-18T17:30:00+00:00": 514.219970703125,
      "2025-03-18T18:30:00+00:00": 515.6699829101562,
      "2025-03-18T19:30:00+00:00": 514.9299926757812
    },
    "sentiment": 0.5380734205245972
  },
  {
    "title": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "published": 1742229360,
    "day_prices": {
      "2025-03-17T13:30:00+00:00": 505.1199951171875,
      "2025-03-17T14:30:00+00:00": 511.1700134277344,
      "2025-03-17T15:30:00+00:00": 507.8599853515625,
      "2025-03-17T16:30:00+00:00": 511.4150085449219,
      "2025-03-17T17:30:00+00:00": 513.3300170898438,
      "2025-03-17T18:30:00+00:00": 515.9500122070312,
      "2025-03-17T19:30:00+00:00": 515.6500244140625
    },
    "sentiment": 0.9419764280319214
  },
  {
    "title": "3 Unstoppable Stocks You Can Buy Now Without Any Hesitation",
    "published": 1742208420,
    "day_prices": {
      "2025-03-17T13:30:00+00:00": 505.1199951171875,
      "2025-03-17T14:30:00+00:00": 511.1700134277344,
      "2025-03-17T15:30:00+00:00": 507.8599853515625,
      "2025-03-17T16:30:00+00:00": 511.4150085449219,
      "2025-03-17T17:30:00+00:00": 513.3300170898438,
      "2025-03-17T18:30:00+00:00": 515.9500122070312,
      "2025-03-17T19:30:00+00:00": 515.6500244140625
    },
    "sentiment": 0.8992733359336853
  },
  {
    "title": "3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now",
    "published": 1741945860,
    "day_prices": {
      "2025-03-14T13:30:00+00:00": 507.0,
      "2025-03-14T14:30:00+00:00": 508.67999267578125,
      "2025-03-14T15:30:00+00:00": 510.1400146484375,
      "2025-03-14T16:30:00+00:00": 505.5799865722656,
      "2025-03-14T17:30:00+00:00": 503.9599914550781,
      "2025-03-14T18:30:00+00:00": 504.6000061035156,
      "2025-03-14T19:30:00+00:00": 504.0400085449219
    },
    "sentiment": 0.9174067974090576
  },
  {
    "title": "CRISPR Therapeutics: An Uninspiring Start For Casgevy",
    "published": 1741898461,
    "day_prices": {
      "2025-03-13T13:30:00+00:00": 493.7900085449219,
      "2025-03-13T14:30:00+00:00": 501.7200012207031,
      "2025-03-13T15:30:00+00:00": 501.010009765625,
      "2025-03-13T16:30:00+00:00": 503.3699951171875,
      "2025-03-13T17:30:00+00:00": 501.260009765625,
      "2025-03-13T18:30:00+00:00": 502.0899963378906,
      "2025-03-13T19:30:00+00:00": 504.8500061035156
    },
    "sentiment": 0.6667029857635498
  },
  {
    "title": "Vertex Pharmaceuticals (VRTX) Outperforms Broader Market: What You Need to Know",
    "published": 1741816819,
    "day_prices": {
      "2025-03-12T13:30:00+00:00": 484.6199951171875,
      "2025-03-12T14:30:00+00:00": 494.2149963378906,
      "2025-03-12T15:30:00+00:00": 491.8550109863281,
      "2025-03-12T16:30:00+00:00": 494.1400146484375,
      "2025-03-12T17:30:00+00:00": 495.9200134277344,
      "2025-03-12T18:30:00+00:00": 493.66400146484375,
      "2025-03-12T19:30:00+00:00": 495.614990234375
    },
    "sentiment": 0.9123228788375854
  },
  {
    "title": "Why Is Vertex (VRTX) Up 7.3% Since Last Earnings Report?",
    "published": 1741793414,
    "day_prices": {
      "2025-03-12T13:30:00+00:00": 484.6199951171875,
      "2025-03-12T14:30:00+00:00": 494.2149963378906,
      "2025-03-12T15:30:00+00:00": 491.8550109863281,
      "2025-03-12T16:30:00+00:00": 494.1400146484375,
      "2025-03-12T17:30:00+00:00": 495.9200134277344,
      "2025-03-12T18:30:00+00:00": 493.66400146484375,
      "2025-03-12T19:30:00+00:00": 495.614990234375
    },
    "sentiment": 0.8309040665626526
  },
  {
    "title": "Tracking Renaissance Technologies 13F Portfolio - Q4 2024 Update",
    "published": 1741728555,
    "day_prices": {
      "2025-03-11T13:30:00+00:00": 496.8599853515625,
      "2025-03-11T14:30:00+00:00": 483.3999938964844,
      "2025-03-11T15:30:00+00:00": 484.9800109863281,
      "2025-03-11T16:30:00+00:00": 484.5450134277344,
      "2025-03-11T17:30:00+00:00": 482.6099853515625,
      "2025-03-11T18:30:00+00:00": 485.989990234375,
      "2025-03-11T19:30:00+00:00": 489.7300109863281
    },
    "sentiment": 0.946245014667511
  },
  {
    "title": "Company News for Mar 11, 2025",
    "published": 1741699320,
    "day_prices": {
      "2025-03-11T13:30:00+00:00": 496.8599853515625,
      "2025-03-11T14:30:00+00:00": 483.3999938964844,
      "2025-03-11T15:30:00+00:00": 484.9800109863281,
      "2025-03-11T16:30:00+00:00": 484.5450134277344,
      "2025-03-11T17:30:00+00:00": 482.6099853515625,
      "2025-03-11T18:30:00+00:00": 485.989990234375,
      "2025-03-11T19:30:00+00:00": 489.7300109863281
    },
    "sentiment": 0.9256495237350464
  },
  {
    "title": "3 Reasons to Avoid VRTX and 1 Stock to Buy Instead",
    "published": 1741683917,
    "day_prices": {
      "2025-03-11T13:30:00+00:00": 496.8599853515625,
      "2025-03-11T14:30:00+00:00": 483.3999938964844,
      "2025-03-11T15:30:00+00:00": 484.9800109863281,
      "2025-03-11T16:30:00+00:00": 484.5450134277344,
      "2025-03-11T17:30:00+00:00": 482.6099853515625,
      "2025-03-11T18:30:00+00:00": 485.989990234375,
      "2025-03-11T19:30:00+00:00": 489.7300109863281
    },
    "sentiment": 0.9410308599472046
  },
  {
    "title": "Vertex Pharmaceuticals Incorporated (VRTX) Leerink's Global Healthcare Conference 2025 (Transcript)",
    "published": 1741618823,
    "day_prices": {
      "2025-03-10T13:30:00+00:00": 483.3900146484375,
      "2025-03-10T14:30:00+00:00": 495.010009765625,
      "2025-03-10T15:30:00+00:00": 499.2789001464844,
      "2025-03-10T16:30:00+00:00": 500.3599853515625,
      "2025-03-10T17:30:00+00:00": 502.54998779296875,
      "2025-03-10T18:30:00+00:00": 501.412109375,
      "2025-03-10T19:30:00+00:00": 501.29998779296875
    },
    "sentiment": 0.9348545670509338
  },
  {
    "title": "3 Magnificent Growth Stocks to Buy in March",
    "published": 1741448460,
    "day_prices": {},
    "sentiment": 0.877232551574707
  },
  {
    "title": "Update: Vertex Pharmaceuticals Says Journavx Non-Opioid Pain Killer Added to Optum Formulary",
    "published": 1741366445,
    "day_prices": {
      "2025-03-07T14:30:00+00:00": 485.7099914550781,
      "2025-03-07T15:30:00+00:00": 487.5849914550781,
      "2025-03-07T16:30:00+00:00": 488.82501220703125,
      "2025-03-07T17:30:00+00:00": 487.7699890136719,
      "2025-03-07T18:30:00+00:00": 491.1300048828125,
      "2025-03-07T19:30:00+00:00": 491.04998779296875,
      "2025-03-07T20:30:00+00:00": 490.4100036621094
    },
    "sentiment": 0.8485729098320007
  },
  {
    "title": "ClearBridge All Cap Growth Strategy Q4 2024 Commentary",
    "published": 1741340400,
    "day_prices": {
      "2025-03-07T14:30:00+00:00": 485.7099914550781,
      "2025-03-07T15:30:00+00:00": 487.5849914550781,
      "2025-03-07T16:30:00+00:00": 488.82501220703125,
      "2025-03-07T17:30:00+00:00": 487.7699890136719,
      "2025-03-07T18:30:00+00:00": 491.1300048828125,
      "2025-03-07T19:30:00+00:00": 491.04998779296875,
      "2025-03-07T20:30:00+00:00": 490.4100036621094
    },
    "sentiment": 0.7719177603721619
  },
  {
    "title": "Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors",
    "published": 1741278960,
    "day_prices": {
      "2025-03-06T14:30:00+00:00": 490.1499938964844,
      "2025-03-06T15:30:00+00:00": 487.81500244140625,
      "2025-03-06T16:30:00+00:00": 489.3599853515625,
      "2025-03-06T17:30:00+00:00": 485.43499755859375,
      "2025-03-06T18:30:00+00:00": 483.510009765625,
      "2025-03-06T19:30:00+00:00": 485.93499755859375,
      "2025-03-06T20:30:00+00:00": 486.55999755859375
    },
    "sentiment": 0.9542815089225769
  },
  {
    "title": "Vertex Pharmaceuticals Inc. stock rises Wednesday, still underperforms market",
    "published": 1741192620,
    "day_prices": {
      "2025-03-05T14:30:00+00:00": 485.25,
      "2025-03-05T15:30:00+00:00": 489.2349853515625,
      "2025-03-05T16:30:00+00:00": 488.92999267578125,
      "2025-03-05T17:30:00+00:00": 489.32501220703125,
      "2025-03-05T18:30:00+00:00": 489.9999084472656,
      "2025-03-05T19:30:00+00:00": 493.4549865722656,
      "2025-03-05T20:30:00+00:00": 493.4549865722656
    },
    "sentiment": 0.578346848487854
  },
  {
    "title": "5 Top Stocks to Buy in March",
    "published": 1741086900,
    "day_prices": {
      "2025-03-04T14:30:00+00:00": 485.489990234375,
      "2025-03-04T15:30:00+00:00": 486.1481018066406,
      "2025-03-04T16:30:00+00:00": 483.375,
      "2025-03-04T17:30:00+00:00": 485.7749938964844,
      "2025-03-04T18:30:00+00:00": 485.510009765625,
      "2025-03-04T19:30:00+00:00": 486.8299865722656,
      "2025-03-04T20:30:00+00:00": 487.8599853515625
    },
    "sentiment": 0.8698464632034302
  },
  {
    "title": "Alger Small Cap Growth Fund Q4 2024 Commentary",
    "published": 1740997440,
    "day_prices": {
      "2025-03-03T14:30:00+00:00": 477.82000732421875,
      "2025-03-03T15:30:00+00:00": 484.2749938964844,
      "2025-03-03T16:30:00+00:00": 485.8599853515625,
      "2025-03-03T17:30:00+00:00": 487.92999267578125,
      "2025-03-03T18:30:00+00:00": 490.0400085449219,
      "2025-03-03T19:30:00+00:00": 489.02099609375,
      "2025-03-03T20:30:00+00:00": 484.0899963378906
    },
    "sentiment": 0.9028429388999939
  }
]